tiprankstipranks
Trending News
More News >
Amicus Therapeutics (FOLD)
NASDAQ:FOLD

Compare Amicus (FOLD) vs. Competitors

Compare
1,100 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Amicus
$14.33
$4.43B
-320.58
53.10%
3 Buy
7 Hold
0 Sell
Moderate Buy
Catalyst Pharma
$22.70
$2.79B
13.25
0.18%
5 Buy
0 Hold
0 Sell
Strong Buy
Travere Therapeutics
$27.87
$2.49B
-25.70
50.89%
11 Buy
2 Hold
0 Sell
Strong Buy
Ocular Therapeutix
$11.27
$2.40B
-7.85
40.00%
8 Buy
0 Hold
0 Sell
Strong Buy
Immunovant
$26.27
$5.29B
-9.29
10.38%
7 Buy
2 Hold
0 Sell
Strong Buy
Disc Medicine
$70.93
$2.68B
-13.24
18.32%
12 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
FOLD
Amicus
14.33
4.82
50.68%
CPRX
Catalyst Pharma
22.70
-0.22
-0.96%
TVTX
Travere Therapeutics
27.87
8.41
43.22%
OCUL
Ocular Therapeutix
11.27
3.18
39.31%
IMVT
Immunovant
26.27
2.68
11.36%
IRON
Disc Medicine
70.93
10.41
17.20%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts